ARTICLE | Clinical News
Firazyr icatibant regulatory update
March 19, 2012 7:00 AM UTC
The Scottish Medicines Consortium recommended the use of Firazyr icatibant from Sanofi on the National Health Service (NHS) in Scotland to treat acute attacks of hereditary angioedema (HAE) in adults ...